The orexigenic hypothalamic neuropeptide MCH/MCH1R-system has been the subject of many studies (for review see: [13], [14]), as functional inhibition of MCH, MCH1R, or a combination of both might result in an anti-obesity treatment [39]. The gene discussed is MCHR1; the disease is obesity disorder.